Turning clinical trials into a hopeful new treatment option. Supporting patients, their families, and their doctors who struggle with finding or choosing treatments, and providing assistance throughout the entire process.
Press
Strategic partnership with eCOA/DCT vendor Xincere to attract more clinical trials to Japan
Attracting clinical trials to Japan in Asia and globally and strengthening DCT and digital clinical trial infrastructure
Buzzreach Inc. (Head office: Minato-ku, Tokyo; Representative Director and CEO: Takateru Inokawa; hereinafter referred to as “Buzzreach”) has entered into a strategic partnership with Xincere Med Tech Inc. (Head office: Shanghai; Founder & CEO: Kevin Lin; hereinafter referred to as “Xincere”), a leading company in the fields of decentralized clinical trials (hereinafter referred to as DCT) and electronic clinical outcome assessment (eCOA).
Through this partnership, the two companies will strengthen collaboration in the areas of technology, platforms, and patient recruitment, with the aim of attracting clinical trials to Japan in Asian and global markets, and accelerating and improving the quality of DCT and digital clinical trials.